← Leaderboards
Elizabeth Kennedy Duperret
University Of Pennsylvania
$169,944
Attributed
$169,944
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $56.7K · FY2014–18$100K$75K$50K$25K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$169,944 · 2
By mechanism
F32$93,698 · 1
F31$76,246 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Dennis E. Discher$22,706,504
- Rashmin C Savani$8,890,174
- Charles P Emerson$35,198,488
- Meenhard Herlyn$50,214,821
- Ellen Pure'$9,984,943
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorPhenotypeSignal TransductionCellsProteinsLaboratoriesPreventSignal PathwayTumor ProgressionExtracellular MatrixTissuesReceptorCause Of DeathArtificial SkinEpithelial To Mesenchymal TransitionBromodeoxyuridineEpidermal Growth Factor ReceptorEpidermisEpithelialCervical Squamous Cell CarcinomaBinding (Molecular Function)Cell Cycle ProgressionCell Cycle ArrestBehavior
Grant awards (4)
Targeting hyaluronan in the tumor microenvironment to improve DNA vaccine immunotherapy$37,004
F32 · FY2018 · CA · contact PI
Targeting hyaluronan in the tumor microenvironment to improve DNA vaccine immunotherapy$56,694
F32 · FY2017 · CA · contact PI
Role of Integrin Alphav in Human Epidermis and Squamous Cell Carcinoma$33,570
F31 · FY2015 · CA · contact PI
Role of Integrin Alphav in Human Epidermis and Squamous Cell Carcinoma$42,676
F31 · FY2014 · CA · contact PI